Bioceres Crop Solutions (BIOX) Equity Income (2016 - 2025)

Bioceres Crop Solutions has disclosed Equity Income across 10 years of filings, most recently posting -$72254.0 for Q4 2025.

• Equity Income for Q4 2025 came in at -$72254.0, down 120.06% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.0 million (down 132.79% YoY), and the FY2025 annual result was -$1.1 million, up 72.19% from the prior year.
• Equity Income came in at -$72254.0 for Q4 2025 at Bioceres Crop Solutions, down from $296772.0 in the prior quarter.
• In the past five years, Equity Income ranged from a high of $8.5 million in Q2 2024 to a low of -$2.3 million in Q2 2025.
• The 5-year median for Equity Income is -$67029.5 (2023), against an average of $268211.5.
• Across the five-year window, Equity Income sank 1829.93% in 2021 and jumped 13879.81% in 2024, its largest moves.
• Bioceres Crop Solutions' Equity Income stood at -$1.1 million in 2021, then surged by 96.49% to -$40048.0 in 2022, then surged by 5224.59% to $2.1 million in 2023, then slumped by 82.45% to $360155.0 in 2024, then slumped by 120.06% to -$72254.0 in 2025.
• The last three Equity Income figures came in at -$72254.0 (Q4 2025), $296772.0 (Q3 2025), and -$2.3 million (Q2 2025), per Business Quant data.